Picture of Forte Biosciences logo

FBRX Forte Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Camac Partners And Atg Capital Management Sent Letter To Stockholders Of Forte Biosciences

Aug 25 (Reuters) - 
  
    * CAMAC PARTNERS AND ATG CAPITAL MANAGEMENT: SENT LETTER TO
STOCKHOLDERS OF FORTE BIOSCIENCES
    * CAMAC PARTNERS AND ATG CAPITAL MANAGEMENT: FILED
DEFINITIVE
PROXY STATEMENT WITH U.S. SEC IN CONNECTION WITH FORTE'S 2023
ANNUAL MEETING
    * CAMAC PARTNERS AND ATG CAPITAL MANAGEMENT: ENCOURAGE FORTE
STOCKHOLDERS TO VOTE FOR INDEPENDENT DIRECTOR CANDIDATES MICHAEL
HACKE AND CHRIS MCINTYRE

Source text for Eikon:  ID:nBw5z4PxVa 
Further company coverage:  FBRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Forte Biosciences

See all news